Упрощенная HTML-версия
208.
Altman R. Risk factors in coronary atherosclerosis athero-inflammation: the
meeting point / R. Altman // Thromb. J. – 2003. – Vol. 1, № 1. – P. 4.
209.
An evidence-based review of patient-centered behavioral interventions for
hypertension / L. Boulware [et al.] // Am J Prev Med. – 2001. – Vol. 21. – P.
221-232.
210.
Angiogenesis research: Guidance for translation to clinical application / J. Folkman
[et al.] // Thrombosis and Haemostasis. – 2001. – Vol. 86, № 1. – P. 23 - 33.
211.
Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose)
polymerase activation / C. Szabo [et al.] // Mol. Med. – 2004. – Vol. 10. – P.
28-35.
212.
Association of fibrinolytic parametrs with early atherosclerosis. The ARIC
study / V. Salomaa [et al. ] // Circulation. – 1995. – Vol. 92. – P. 284-290.
213.
Association of increased intramyocellular lipid content with insulin resistance
in lean nondiabetic offspring of type 2 diabetic subjects / S. Jacob [et al.] //
Diabetes. – 1999. – Vol. 48. – P. 1113–1119.
214.
Association of sICAM-1 and MCP-1 with coronary artery calcification in
families enriched for coronary heart disease or hypertension: the NHLBI
Family Heart Study / W. Tang [et al.] // BMC. Cardiovasc. Disord. – 2007. - №
7. – P. 30.
215.
Atheroprotective Mechanisms Activated by Fluid Shear Stress in Endothelial
Cells / B.C. Berk [et al.] // Drug News Perspect. – 2002. – Vol.15, № 3. – P.
133-139.
216.
Bell-Anderson K. S. Leptin as a potential treatment for obesity: progress to
date / K. S. Bell-Anderson // Treat Endocrinol. – 2004. – Vol. 3. – P. 11-18.
217.
Bjorntorp P. Obesity / P. Bjorntorp // Lancet. – 1997. – Vol.350. – P. 423–426.
218.
Blood pressure and stroke: an overview of published reviews / C. M. Lawes [et
al.] // Stroke. – 2004. – Vol. 35. – P. 776–785.
219.
Body mass index and the prevalence of hypertension and dyslipidemia / C.D.
[et al.] // Obes Res. – 2000. – Vol.8, № 9. – Р. 676-677.